Jsafra-Asset-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-25
Total Holdings
305
Total Value
1199167396
Accession Number
0001535293-25-000003
Form Type
13F-HR
Manager Name
Jsafra-Asset-Management
Data Enrichment
88% identified
269 identified36 unidentified

Holdings

305 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 15 of 16
MOLINA HEALTHCARE, INC.
Shares:2
Value:$659
% of Portfolio:0.0% ($659/$1.2B)
REGENERON PHARMACEUTICALS, INC.
Shares:1
Value:$634
% of Portfolio:0.0% ($634/$1.2B)
PROCEPT BioRobotics Corp
Shares:9
Value:$524
% of Portfolio:0.0% ($524/$1.2B)
LifeStance Health Group, Inc.
Shares:78
Value:$519
% of Portfolio:0.0% ($519/$1.2B)
Merus N.V.
Shares:12
Value:$505
% of Portfolio:0.0% ($505/$1.2B)
SOLENO THERAPEUTICS INC
Shares:7
Value:$500
% of Portfolio:0.0% ($500/$1.2B)
Nuvalent, Inc.
Shares:7
Value:$496
% of Portfolio:0.0% ($496/$1.2B)
BRUKER CORP
Shares:11
Value:$459
% of Portfolio:0.0% ($459/$1.2B)
WEST PHARMACEUTICAL SERVICES INC
Shares:2
Value:$448
% of Portfolio:0.0% ($448/$1.2B)
Phreesia, Inc.
Shares:16
Value:$409
% of Portfolio:0.0% ($409/$1.2B)
Viridian Therapeutics, Inc.\DE
Shares:30
Value:$404
% of Portfolio:0.0% ($404/$1.2B)
Arcellx, Inc.
Shares:6
Value:$394
% of Portfolio:0.0% ($394/$1.2B)
Janux Therapeutics, Inc.
Shares:14
Value:$378
% of Portfolio:0.0% ($378/$1.2B)
Xenon Pharmaceuticals Inc.
Shares:11
Value:$369
% of Portfolio:0.0% ($369/$1.2B)
Crinetics Pharmaceuticals, Inc.
Shares:11
Value:$369
% of Portfolio:0.0% ($369/$1.2B)
10x Genomics, Inc.
Shares:39
Value:$340
% of Portfolio:0.0% ($340/$1.2B)
MoonLake Immunotherapeutics
Shares:8
Value:$313
% of Portfolio:0.0% ($313/$1.2B)
Disc Medicine, Inc.
Shares:6
Value:$298
% of Portfolio:0.0% ($298/$1.2B)
Revolution Medicines, Inc.
Shares:8
Value:$283
% of Portfolio:0.0% ($283/$1.2B)
07725L102
Shares:1
Value:$272
% of Portfolio:0.0% ($272/$1.2B)